{"version":"1.0","provider_name":"European Scientist","provider_url":"https:\/\/www.europeanscientist.com\/en\/","author_name":"European Scientist","author_url":"https:\/\/www.europeanscientist.com\/en\/author\/eseditor1\/","title":"UK aims to remain part of ECHA after Brexit","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"kgB10DwxZR\"><a href=\"https:\/\/www.europeanscientist.com\/en\/public-health\/uk-bids-remain-part-echa-brexit\/\">UK aims to remain part of ECHA after Brexit<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.europeanscientist.com\/en\/public-health\/uk-bids-remain-part-echa-brexit\/embed\/#?secret=kgB10DwxZR\" width=\"600\" height=\"338\" title=\"&#8220;UK aims to remain part of ECHA after Brexit&#8221; &#8212; European Scientist\" data-secret=\"kgB10DwxZR\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.europeanscientist.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.europeanscientist.com\/wp-content\/uploads\/2018\/01\/url-16.jpg","thumbnail_width":615,"thumbnail_height":409,"description":"Britain is pushing to remain subject to EU regulation for medicines after Brexit as not participating would create \u201cserious competitive disadvantage\u201d, says CBI The UK could still be under the bloc\u2019s rules regarding medicine post-Brexit. The Confederation of British Industry, an organisation representing 190,000 UK businesses, recommended in a December report,The room where it happens, [&hellip;]"}